CD40 and lung carcinoma: Here, our experimental protocol proved effective in introducing Hesperetin onto nanoparticles, enabling the inhalation of the nanoparticles, and eventually releasing Hesperetin in lung cancer tissues where, along with free immunoadjuvant anti-CD40, they reduced or eliminated the growth of implanted lung tumors.